No Increase Seen in Pediatric Hepatitis in the United States
No increase in acute hepatitis of unspecified etiology, adenovirus types 40/41 above prepandemic baseline levels.
Hepatology Information Center
Mystery of Pediatric Hepatitis Cases Deepens as CDC Probe Continues
One more US death related to pediatric hepatitis was reported.
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis.
Universal Hepatitis B Vaccination Recommended for Adults Aged 19 to 59 Years
CDC updates hepatitis B vaccination recommendation for adults
Testing, Treatment Initiations for Hepatitis C Decreased During the COVID-19 Pandemic
In this study, researchers assessed the nationwide rate of testing and treatment initiations for hepatitis C virus infection in the United States following the onset of the COVID-19 pandemic through the end of 2020.
Hepatitis C Virus Positivity Linked to Schizophrenia Development
Incidence of overall mortality was also highest for untreated patients with hepatitis C virus.
ACIP: 2022 Adult Immunization Schedule Updates
The 2022 adult immunization schedule summarizes ACIP recommendations, including several changes.
High Immunogenicity Observed Among Healthy Adults After 3 Doses of the 3-Antigen Formulation Hepatitis B Vaccine
Investigators assessed the manufacturing consistency, safety, and efficacy of a 3-antigen hepatitis B vaccine vs a single-antigen formulation.
Regular Thyroid Screening Recommended for People With Hepatitis C
People with hepatitis C are at an increased risk for several autoimmune disorders. Researchers sought to discover a link between the virus and hypothyroidism.
Atypical Celiac Disease: Diagnosing Nonintestinal Cases in Primary Care
Atypical celiac disease may present as dermatitis herpetiformis, anemia, elevated transaminases, short stature, and osteopenia/osteoporosis.
HCV Treatment Declined Nearly Twofold Between 2015 and 2020
The COVID-19 pandemic and opioid crisis created new barriers to HCV treatment, leading to the lowest annual treatment rate in 5 years.
Top November & December 2021 FDA Approvals
November and December 2021 FDA drug approvals include treatments for hepatitis B, achondroplasia, cancer, and polycythemia vera.
Hepatitis B Shots Advised for All US Adults Younger Than 60 Years
Until now, the shots were recommended only for certain groups of adults.
Medication Treatments Lacking for Active Opioid Use Disorder in Veterans With Cirrhosis
Investigators assessed the factors associated with medication treatment for opioid use disorder and whether it is linked to hepatic decompensation or death in patients with cirrhosis and active opioid use disorder.
Challenges in Managing Increasing Infection Rates in Cirrhosis
The natural history of cirrhosis is significantly affected by the increasing prevalence of infections, with strategies for prevention and treatment difficult to compose.
Sleep-Wake Disturbance Highly Prevalent in Populations With Liver Disease
Researchers summarized the reciprocal interaction between sleep and liver diseases, including cirrhosis, and investigated potential approaches for therapeutic interventions.
Epstein-Barr Virus: Forgotten Etiology of Hepatic Injury
Epstein-Barr virus infection may present with liver injury characterized by acute cholestatic hepatitis, as demonstrated in this case.
Pharmacotherapies for Liver Fibrosis, NASH Resolution Ranked
Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.
Opioid Agonist Therapy Linked to Increased HCV Treatment Rates in People Who Inject Drugs
Researchers studied the impact of current opioid agonist therapy on initiation of chronic hepatitis C virus treatment among a population of individuals who inject drugs.
Better Strategies Needed for Managing NAFLD in Adults
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hepatology Information Center
Loading... 
Loading...